LIFECORE BIOMEDICAL, INC. (LFCR) Free cash flow 2016–2025
LIFECORE BIOMEDICAL, INC. (LFCR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$13.6MFY2025 · since FY2016: -$18.9M → -$13.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.6M | +24.9% |
| FY2024 | -$18.1M | — |
| FY2022 | -$48.8M | -1647.9% |
| FY2021 | -$2.8M | +90.5% |
| FY2020 | -$29.3M | -1.9% |
| FY2019 | -$28.7M | -107.9% |
| FY2018 | -$13.8M | -302.1% |
| FY2017 | $6.8M | +136.1% |
| FY2016 | -$18.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice